Valuation: RaySearch Laboratories AB

Market Cap 5.98B 620M 542M 500M 461M 869M 59.74B 888M 2.35B 29.26B 2.33B 2.28B 101B P/E 2026 *
21.1x
P/E 2027 * 17.2x
Enterprise Value 6.14B 637M 556M 513M 473M 892M 61.31B 912M 2.41B 30.02B 2.39B 2.34B 103B EV / Sales 2026 *
4.35x
EV / Sales 2027 * 3.62x
Free-Float
80.09%
Yield 2026 *
2.29%
Yield 2027 * 2.91%
1 day-4.30%
1 week-25.77%
Current month-20.90%
1 month-15.93%
3 months-24.15%
6 months-18.55%
Current year-23.98%
1 week 161
Extreme 161
234.4
1 month 161
Extreme 161
236.8
Current year 161
Extreme 161
237
1 year 161
Extreme 161
368
3 years 63.1
Extreme 63.1
369.5
5 years 40.8
Extreme 40.8
369.5
10 years 40.8
Extreme 40.8
369.5
Manager TitleAgeSince
Chief Executive Officer 57 1999-12-31
Director of Finance/CFO 48 2025-01-26
Chief Tech/Sci/R&D Officer 53 2015-08-27
Director TitleAgeSince
Director/Board Member 57 1999-12-31
Chairman 81 2016-11-17
Chairman 87 2022-09-29
Change 5-day change 1-year change 3-year change Capi.($)
-4.30%-25.77% - - 620M
-1.01%+2.77%-30.79%-6.68% 31.74B
-3.46%-5.05%-42.95%+184.23% 13.65B
-1.43%-2.55%-24.06%+67.70% 5.5B
-4.20%-6.89% - - 2.15B
-2.40%+2.11%+70.65%-32.02% 2.09B
-0.73%-5.34% - - 1.74B
-4.23%-2.47%-39.86% - 1.07B
-3.80%-5.00%+45.69%+106.33% 901M
-6.74%-2.64%-41.34%-55.97% 759M
Average -3.23%-2.78%-8.95%+43.93% 6.62B
Weighted average by Cap. -1.96%-0.40%-28.39%+48.72%

Financials

2026 *2027 *
Net sales 1.41B 146M 128M 118M 109M 205M 14.11B 210M 555M 6.91B 550M 538M 23.79B 1.65B 171M 149M 138M 127M 239M 16.46B 245M 648M 8.06B 642M 628M 27.75B
Net income 280M 29.05M 25.39M 23.43M 21.59M 40.7M 2.8B 41.6M 110M 1.37B 109M 107M 4.72B 341M 35.38M 30.92M 28.53M 26.3M 49.57M 3.41B 50.67M 134M 1.67B 133M 130M 5.74B
Net Debt 157M 16.29M 14.23M 13.14M 12.11M 22.82M 1.57B 23.33M 61.75M 768M 61.17M 59.83M 2.64B -7M -726K -635K -586K -540K -1.02M -69.94M -1.04M -2.75M -34.25M -2.73M -2.67M -118M
Logo RaySearch Laboratories AB
RaySearch Laboratories AB (publ) is a Sweden-based medical technology company that develops software for radiation therapy of cancer. It markets and sells its products mainly in the United States and in Europe through license agreements with medical technology companies and scientific institutions. Additionally, its solutions include software for optimizing Intensity Modulated Radiation Therapy (IMRT) plans for photons, adaptive technology for IMRT treatments and software for proton treatments. The Company’s commercial partners are Philips, Nucletron and IBA Dosimetry, among others. In April 2014, it established a German subsidiary, RaySearch Germany GmbH.
Employees
465
Date Price Change Volume
26-07-17 SEK 179.45 +6.11% 10,809
26-07-16 SEK 169.11 -23.91% 45,937
26-07-15 SEK 222.25 -2.52% 1,512
26-07-14 SEK 228.00 -1.54% 16,673
26-07-13 SEK 231.56 -1.04% 1,961
Trader
Investor
Global
Quality
ESG MSCI
CCC
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
174.40SEK
Average target price
330.00SEK
Spread / Average Target
+89.22%

Quarterly revenue - Rate of surprise